HB 7749, the "Quantum in Practice Act," makes two narrow but consequential edits to the National Quantum Initiative Act: it inserts “modeling, simulation” into the statutory definition of quantum information science and adds “quantum molecular modeling or simulation” to the list of research topics in the Act’s quantum information science research program. The amendments are textual changes to existing statute; the bill does not itself authorize new funding.
Those textual edits matter because they change what federal agencies that administer the National Quantum Initiative (NQI) can treat as within the program’s remit. By naming modeling and molecular simulation, the bill signals a congressional preference that NQI-funded efforts explicitly support quantum-enabled molecular science—work with direct commercial pathways in pharmaceuticals, energy storage, materials, and agricultural chemistry.
However, the bill leaves key implementation choices—budgeting, agency priorities, export-control coordination—to the agencies that run the program.
At a Glance
What It Does
The bill amends two provisions of the National Quantum Initiative Act: it expands the statutory definition of “quantum information science” to include “modeling, simulation,” and it adds “quantum molecular modeling or simulation” to the research program list at 15 U.S.C. 8851(b)(3). These are textual changes to program scope rather than funding or oversight directives.
Who It Affects
Federal science agencies that implement NQI programs (NIST, NSF, DOE and others), national laboratories and university research centers that pursue quantum information science, and industries that would use quantum molecular simulations—pharmaceuticals, materials, battery manufacturers, and agricultural-chemistry firms.
Why It Matters
By explicitly naming modeling and molecular simulation, the bill signals a shift in federal R&D priorities within the NQI framework. Agencies can use the statutory language to justify request-for-proposal topics, grant solicitations, and partnerships aimed at applied molecular problems, which could redirect competitive funding and program attention toward quantum-enabled molecular science.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill makes two surgical edits to the National Quantum Initiative Act. First, it broadens the Act’s working definition of “quantum information science” to cover modeling and simulation alongside computing and sensing.
Second, it inserts “quantum molecular modeling or simulation” into the enumerated topics for the NQI research program. Those two insertions are short but meaningful: they change what types of projects fall within the statute’s description of NQI work and therefore what kinds of project descriptions and priority areas agencies can legitimately pursue under that law.
Because the changes are definitional and programmatic rather than appropriations-based, they do not by themselves move money. Instead, they operate by changing the legal language that agencies use when designing solicitations, interagency initiatives, and cooperative agreements.
Practically, program managers at agencies like NSF, DOE, and NIST could broaden funding announcements to explicitly include quantum molecular simulation, prioritize partnerships with chemistry and materials science units, or expand workforce training programs to include simulation expertise.The law’s new focus on molecular modeling ties quantum information science to applied industrial problems—drug discovery, battery chemistry, catalyst design, advanced materials, and synthetic fertilizer processes described in the bill’s findings. That orientation increases the likelihood of public–private collaboration but also raises coordination questions: which agency leads particular efforts, how to manage intellectual property and commercialization pathways, and how to align with export-control regimes that already govern certain quantum technologies.Finally, the bill does not modify other statutory requirements tied to NQI governance, such as the roles of the National Quantum Coordination Office or interagency reporting obligations.
Implementation therefore depends on agency rulemaking, internal program priorities, and appropriation language in future spending bills rather than on new statutory funding or oversight structures included in HB 7749.
The Five Things You Need to Know
The bill adds the phrase “modeling, simulation” to the statutory definition of “quantum information science” at 15 U.S.C. 8801(6).
It inserts a new subparagraph (H) into 15 U.S.C. 8851(b)(3) to list “quantum molecular modeling or simulation” as a covered research topic for the NQI research program.
HB 7749 is strictly a definitional/programmatic amendment and does not appropriate funds or create new grant authorities; agencies must use existing appropriations to act on the expanded language.
The statutory change can be used by agencies to shape solicitations, challenge-problem competitions, and collaborative programs that explicitly target quantum-enabled molecular science (e.g.
drug design, catalysis, battery chemistry).
The bill does not address intellectual property allocation, export controls, or security review processes that are likely to arise when quantum molecular simulation work has commercial or dual-use applications.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title
Gives the bill the public name “Quantum in Practice Act.” This is a labeling choice that frames congressional intent toward practical, application-driven quantum research rather than basic theoretical work; that framing can influence legislative and agency communications even though it has no independent legal effect.
Congressional findings on molecular simulation use cases
Lists Congress’s rationale for the amendment and enumerates potential application areas—fertilizer synthesis, medicines, batteries, lighter/stronger metals, protective materials, and superconductors. The findings don’t create legal obligations, but they provide interpretive context agencies and grant panels will use when prioritizing proposals and justifying programmatic emphasis on molecular applications.
Expand definition of quantum information science
Amends 15 U.S.C. 8801(6) by inserting “modeling, simulation” after “computing.” That change broadens the scope of what is captured under the statutory term “quantum information science,” which agencies reference when defining program boundaries, creating solicitations, and reporting on NQI activities. Practically, this reduces ambiguity about whether modeling and simulation projects fall inside or outside NQI’s remit.
Add quantum molecular modeling to NQI research program topics
Amends 15 U.S.C. 8851(b)(3) by adding a new subparagraph (H) specifically naming “quantum molecular modeling or simulation.” This provides an explicit statutory hook agencies can cite when funding or coordinating projects in molecular simulation, and it may influence who reviews proposals and which program offices lead interdisciplinary work.
This bill is one of many.
Codify tracks hundreds of bills on Science across all five countries.
Explore Science in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Academic and national-lab researchers in computational chemistry and materials science — the bill gives them an explicit statutory basis to compete for NQI funds on molecular simulation topics and to form interdisciplinary proposals with quantum hardware groups.
- Pharmaceutical and materials companies — clearer federal emphasis on quantum molecular simulation increases the odds of public–private partnerships, cooperative research awards, and early access to research testbeds to accelerate discovery cycles.
- U.S. national laboratories and HPC centers — lawfully broadening NQI scope strengthens their case to host quantum simulation testbeds and to receive cross-agency tasking for large-scale simulation projects.
Who Bears the Cost
- Federal implementing agencies (NIST, NSF, DOE and the National Quantum Coordination Office) — must update program plans, solicitations, reporting templates, and interagency coordination mechanisms; these administrative costs arrive without additional appropriations in the bill.
- Other quantum research areas — program attention and competitive funding within NQI may shift toward molecular simulation, making it harder for projects in other QIS subfields to capture scarce grant dollars.
- Small academic groups and non-traditional applicants — increased emphasis on molecular simulation that leans on high-performance testbeds could favor institutions with expensive infrastructure and reduce competitiveness of smaller teams that lack access to large-scale hardware.
Key Issues
The Core Tension
The bill faces a classic trade-off: directing federal R&D toward near-term, application-oriented quantum molecular simulation promises faster commercial and economic benefits, but doing so risks reallocating scarce programmatic resources away from basic quantum research and raises security, export-control, and IP coordination challenges that the bill does not resolve.
The bill’s core effect is definitional: it changes what the National Quantum Initiative can be interpreted to cover. That has advantages (clarity for applicants, a legislative signal to agencies) but also limits: there is no new funding, no designated lead agency for molecular simulation, and no mandate on how to handle commercialization or national-security review.
Agencies must translate the statutory text into program actions using existing budgets and administrative capacity, and those choices will determine whether this amendment yields tangible research support or only symbolic emphasis.
Two implementation questions loom. First, how will agencies delineate “quantum molecular modeling or simulation” from classical high-performance computing modeling efforts?
If agencies treat the term broadly, there is risk of duplication with DOE’s existing computational chemistry programs. Second, the bill is silent on export controls, data-security standards, and IP terms for public–private projects—issues that routinely arise when advanced simulation capabilities accelerate commercial development.
Absent coordination with Commerce, State, and defense-related export-control frameworks, litigation or administrative friction could slow technology transfer and commercialization.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.